Cardiovascular Risk in Psoriatic Disease


Findings from the first real-world study of gaps in care for hypertension and dyslipidemia in patients with psoriasis and psoriatic arthritis.

References1. Agca R, Heslinga SC, Rollefstad S, et al. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis 2017;76:17-28.2. Anderson TJ, Grégoire J, Hegele RA, et al. 2012 update of the Canadian Cardiovascular Society guidelines for the diagnosis and treatment of dyslipidemia for the prevention of cardiovascular disease in the adult. Can J Cardiol. 2013;29:151-67.3. Eder L, Harvey P, Chandran V, et al. Gaps in Diagnosis and Treatment of Cardiovascular Risk Factors in Patients with Psoriatic Disease: An International Multicenter Study. J Rheumatol. 2018 Feb 1. pii: jrheum.170379. doi: 10.3899/jrheum.170379.

Related Videos
© 2023 MJH Life Sciences

All rights reserved.